Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling
Jean Christopher Chamcheu, Islam Rady, Roxane-Cherille N Chamcheu, Abu Bakar Siddique, Melissa B Bloch, Sergette Banang Mbeumi, Abiola S Babatunde, Mohammad B Uddin, Felicite K Noubissi, Peter W Jurutka, Yong-Yu Liu, Vladimir S Spiegelman, G Kerr Whitfield, Khalid A El Sayed, Jean Christopher Chamcheu, Islam Rady, Roxane-Cherille N Chamcheu, Abu Bakar Siddique, Melissa B Bloch, Sergette Banang Mbeumi, Abiola S Babatunde, Mohammad B Uddin, Felicite K Noubissi, Peter W Jurutka, Yong-Yu Liu, Vladimir S Spiegelman, G Kerr Whitfield, Khalid A El Sayed
Abstract
Non-melanoma skin cancers (NMSCs) are the leading cause of skin cancer-related morbidity and mortality. Effective strategies are needed to control NMSC occurrence and progression. Non-toxic, plant-derived extracts have been shown to exert multiple anti-cancer effects. Graviola (Annona muricata), a tropical fruit-bearing plant, has been used in traditional medicine against multiple human diseases including cancer. The current study investigated the effects of graviola leaf and stem extract (GLSE) and its solvent-extracted fractions on two human NMSC cell lines, UW-BCC1 and A431. GLSE was found to: (i) dose-dependently suppress UW-BCC1 and A431 cell growth, motility, wound closure, and clonogenicity; (ii) induce G₀/G₁ cell cycle arrest by downregulating cyclin/cdk factors while upregulating cdk inhibitors, and (iii) induce apoptosis as evidenced by cleavage of caspases-3, -8 and PARP. Further, GLSE suppressed levels of activated hedgehog (Hh) pathway components Smo, Gli 1/2, and Shh while inducing SuFu. GLSE also decreased the expression of pro-apoptotic protein Bax while decreasing the expression of the anti-apoptotic protein Bcl-2. We determined that these activities were concentrated in an acetogenin/alkaloid-rich dichloromethane subfraction of GLSE. Our data identify graviola extracts and their constituents as promising sources for new chemopreventive and therapeutic agent(s) to be further developed for the control of NMSCs.
Keywords: Annona muricata; Hedgehog signaling pathway; apoptosis; basal cell carcinoma; cutaneous squamous cell carcinoma; graviola; natural products chemistry; non-melanoma skin cancer.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
- Fahradyan A., Howell A.C., Wolfswinkel E.M., Tsuha M., Sheth P., Wong A.K. Updates on the Management of Non-Melanoma Skin Cancer (NMSC) Healthcare (Basel) 2017;5:82. doi: 10.3390/healthcare5040082.
- Eisemann N., Waldmann A., Geller A.C., Weinstock M.A., Volkmer B., Greinert R., Breitbart E.W., Katalinic A. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J. Investig. Dermatol. 2014;134:43–50. doi: 10.1038/jid.2013.304.
- Kim T., Havighurst T., Kim K., Hebbring S.J., Ye Z., Aylward J., Keles S., Xu Y.G., Spiegelman V.S. RNA-Binding Protein IGF2BP1 in Cutaneous Squamous Cell Carcinoma. J. Investig. Dermatol. 2017;137:772–775. doi: 10.1016/j.jid.2016.10.042.
- Marzuka A.G., Book S.E. Basal cell carcinoma: Pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J. Biol. Med. 2015;88:167–179.
- Guy G.P., Jr., Machlin S.R., Ekwueme D.U., Yabroff K.R. Prevalence and costs of skin cancer treatment in the U.S., 2002–2006 and 2007–2011. Am. J. Prev. Med. 2015;48:183–187. doi: 10.1016/j.amepre.2014.08.036.
- Guy G.P., Jr., Thomas C.C., Thompson T., Watson M., Massetti G.M., Richardson L.C. Vital signs: Melanoma incidence and mortality trends and projections—United States, 1982–2030. MMWR Morb. Mortal. Wkly. Rep. 2015;64:591–596.
- Robinson J.K. Sun exposure, sun protection, and vitamin D. JAMA. 2005;294:1541–1543. doi: 10.1001/jama.294.12.1541.
- Stern R.S. Prevalence of a history of skin cancer in 2007: Results of an incidence-based model. Arch. Dermatol. 2010;146:279–282. doi: 10.1001/archdermatol.2010.4.
- Rogers H.W., Weinstock M.A., Feldman S.R., Coldiron B.M. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. JAMA Dermatol. 2015;151:1081–1086. doi: 10.1001/jamadermatol.2015.1187.
- Van der Geer S., Siemerink M., Reijers H.A., Verhaegh M.E., Ostertag J.U., Neumann H.A., Krekels G.A. The incidence of skin cancer in dermatology. Clin. Exp. Dermatol. 2013;38:724–729. doi: 10.1111/ced.12080.
- Tarallo M., Cigna E., Frati R., Delfino S., Innocenzi D., Fama U., Corbianco A., Scuderi N. Metatypical basal cell carcinoma: A clinical review. J. Exp. Clin. Cancer Res. 2008;27:65. doi: 10.1186/1756-9966-27-65.
- Athar M., Li C., Kim A.L., Spiegelman V.S., Bickers D.R. Sonic hedgehog signaling in Basal cell nevus syndrome. Cancer Res. 2014;74:4967–4975. doi: 10.1158/0008-5472.CAN-14-1666.
- Noubissi F.K., Kim T., Kawahara T.N., Aughenbaugh W.D., Berg E., Longley B.J., Athar M., Spiegelman V.S. Role of CRD-BP in the growth of human basal cell carcinoma cells. J. Investig. Dermatol. 2014;134:1718–1724. doi: 10.1038/jid.2014.17.
- Anand P., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Tharakan S.T., Lai O.S., Sung B., Aggarwal B.B. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 2008;25:2097–2116. doi: 10.1007/s11095-008-9661-9.
- Stratigos A., Garbe C., Lebbe C., Malvehy J., del Marmol V., Pehamberger H., Peris K., Becker J.C., Zalaudek I., Saiag P., et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur. J. Cancer. 2015;51:1989–2007. doi: 10.1016/j.ejca.2015.06.110.
- Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br. J. Dermatol. 2012;166:1069–1080. doi: 10.1111/j.1365-2133.2012.10830.x.
- Nowotarski S.L., Feith D.J., Shantz L.M. Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines. Cancer Growth Metastasis. 2015;8:17–27. doi: 10.4137/CGM.S21219.
- Cronin K.A., Lake A.J., Scott S., Sherman R.L., Noone A.M., Howlader N., Henley S.J., Anderson R.N., Firth A.U., Ma J., et al. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer. 2018 doi: 10.1002/cncr.31551.
- Pleasance E.D., Cheetham R.K., Stephens P.J., McBride D.J., Humphray S.J., Greenman C.D., Varela I., Lin M.L., Ordonez G.R., Bignell G.R., et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 2010;463:191–196. doi: 10.1038/nature08658.
- Rippey J.J. Why classify basal cell carcinomas? Histopathology. 1998;32:393–398. doi: 10.1046/j.1365-2559.1998.00431.x.
- Xiang F., Lucas R., Hales S., Neale R. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978–2012: Empirical relationships. JAMA Dermatol. 2014;150:1063–1071. doi: 10.1001/jamadermatol.2014.762.
- Ananthaswamy H.N., Pierceall W.E. Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem. Photobiol. 1990;52:1119–1136. doi: 10.1111/j.1751-1097.1990.tb08452.x.
- Gupta S., Takebe N., Lorusso P. Targeting the Hedgehog pathway in cancer. Ther. Adv. Med. Oncol. 2010;2:237–250. doi: 10.1177/1758834010366430.
- Bale A.E., Yu K.P. The hedgehog pathway and basal cell carcinomas. Hum. Mol. Genet. 2001;10:757–762. doi: 10.1093/hmg/10.7.757.
- Ciani F., Tafuri S., Troiano A., Cimmino A., Fioretto B.S., Guarino A.M., Pollice A., Vivo M., Evidente A., Carotenuto D., et al. Anti-proliferative and pro-apoptotic effects of Uncaria tomentosa aqueous extract in squamous carcinoma cells. J. Ethnopharmacol. 2018;211:285–294. doi: 10.1016/j.jep.2017.09.031.
- Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629–661. doi: 10.1021/acs.jnatprod.5b01055.
- Schmidt B., Ribnicky D.M., Poulev A., Logendra S., Cefalu W.T., Raskin I. A natural history of botanical therapeutics. Metabolism. 2008;57:39. doi: 10.1016/j.metabol.2008.03.001.
- Gavamukulya Y., Wamunyokoli F., El-Shemy H.A. Annona muricata: Is the natural therapy to most disease conditions including cancer growing in our backyard? A systematic review of its research history and future prospects. Asian Pac. J. Trop. Med. 2017;10:835–848. doi: 10.1016/j.apjtm.2017.08.009.
- Moghadamtousi S.Z., Fadaeinasab M., Nikzad S., Mohan G., Ali H.M., Kadir H.A. Annona muricata (Annonaceae): A Review of Its Traditional Uses, Isolated Acetogenins and Biological Activities. Int. J. Mol. Sci. 2015;16:15625–15658. doi: 10.3390/ijms160715625.
- Coria-Tellez A.V., Montalvo-Gonzalez E., Yahia E.M., Obledo-Vazquez E.N. Annona muricata: A comprehensive review on its traditional medicinal uses, phytochemicals, pharmacological activities, mechanisms of action and toxicity. Arab. J. Chem. 2017;30 doi: 10.1016/j.arabjc.2016.01.004.
- Torres M.P., Rachagani S., Purohit V., Pandey P., Joshi S., Moore E.D., Johansson S.L., Singh P.K., Ganti A.K., Batra S.K. Graviola: A novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Lett. 2012;323:29–40. doi: 10.1016/j.canlet.2012.03.031.
- Prabhakaran K., Ramasamy G., Doraisamy U., Mannu J.K.R., Murugesan J.R. Polyketide Natural Products, Acetogenins from Graviola (Annona muricata L), its Biochemical, Cytotoxic Activity and Various Analyses Through Computational and Bio-Programming Methods. Curr. Pharm. Des. 2016;22:5204–5210. doi: 10.2174/1381612822666160531163144.
- Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., Parks W.P. In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 1973;51:1417–1423. doi: 10.1093/jnci/51.5.1417.
- Chen A., Huang X., Xue Z., Cao D., Huang K., Chen J., Pan Y., Gao Y. The Role of p21 in Apoptosis, Proliferation, Cell Cycle Arrest, and Antioxidant Activity in UVB-Irradiated Human HaCaT Keratinocytes. Med. Sci. Monit. Basic Res. 2015;21:86–95.
- Soldani C., Scovassi A.I. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update. Apoptosis Int. J. Progr. Cell Death. 2002;7:321–328. doi: 10.1023/A:1016119328968.
- Ebrahim H.Y., Akl M.R., Elsayed H.E., Hill R.A., El Sayed K.A. Usnic Acid Benzylidene Analogues as Potent Mechanistic Target of Rapamycin Inhibitors for the Control of Breast Malignancies. J. Nat. Prod. 2017;80:932–952. doi: 10.1021/acs.jnatprod.6b00917.
- Ebrahim H.Y., Mohyeldin M.M., Hailat M.M., El Sayed K.A. (1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies. Bioorg. Med. Chem. 2016;24:5748–5761. doi: 10.1016/j.bmc.2016.09.032.
- Elsayed H.E., Ebrahim H.Y., Haggag E.G., Kamal A.M., El Sayed K.A. Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies. Bioorg. Med. Chem. 2017;25:6297–6312. doi: 10.1016/j.bmc.2017.09.033.
- Rady I., Bloch M.B., Chamcheu R.-C.N., Banang-Mbeumi S., Anwar M.R., Mohamed H., Babatunde A.S., Kuiate J.R., Noubissi F.K., El Sayed K.A., et al. Anti-cancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review. Oxidative Medicine and Cellular Longevity. 2018 In press.
- Ekstrom A.M., Serafini M., Nyren O., Hansson L.E., Ye W., Wolk A. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: A population-based case-control study in Sweden. Int. J. Cancer. 2000;87:133–140. doi: 10.1002/1097-0215(20000701)87:1<133::AID-IJC20>;2-E.
- Guo W.D., Hsing A.W., Li J.Y., Chen J.S., Chow W.H., Blot W.J. Correlation of cervical cancer mortality with reproductive and dietary factors, and serum markers in China. Int. J. Epidemiol. 1994;23:1127–1132. doi: 10.1093/ije/23.6.1127.
- Kellen E., Zeegers M., Paulussen A., Van Dongen M., Buntinx F. Fruit consumption reduces the effect of smoking on bladder cancer risk. The Belgian case control study on bladder cancer. Int. J. Cancer. 2006;118:2572–2578. doi: 10.1002/ijc.21714.
- Liu R.H. Dietary bioactive compounds and their health implications. J. Food Sci. 2013;78(Suppl. 1):A18–A25. doi: 10.1111/1750-3841.12101.
- Syed D.N., Mukhtar H. Botanicals for the prevention and treatment of cutaneous melanoma. Pigment Cell. Melanoma Res. 2011;24:688–702. doi: 10.1111/j.1755-148X.2011.00851.x.
- Syed D.N., Chamcheu J.C., Adhami V.M., Mukhtar H. Pomegranate extracts and cancer prevention: Molecular and cellular activities. Anti-Cancer Agents Med. Chem. 2013;13:1149–1161. doi: 10.2174/1871520611313080003.
- Kim J. Protective effects of Asian dietary items on cancers—Soy and ginseng. Asian Pac. J. Cancer Prev. 2008;9:543–548.
- Lansky E.P., Jiang W., Mo H., Bravo L., Froom P., Yu W., Harris N.M., Neeman I., Campbell M.J. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Investig. New Drugs. 2005;23:11–20. doi: 10.1023/B:DRUG.0000047101.02178.07.
- Seeram N.P., Adams L.S., Hardy M.L., Heber D. Total cranberry extract versus its phytochemical constituents: Antiproliferative and synergistic effects against human tumor cell lines. J. Agric. Food Chem. 2004;52:2512–2517. doi: 10.1021/jf0352778.
- Viladomiu M., Hontecillas R., Lu P., Bassaganya-Riera J. Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents. Evid.-Based Complement. Alternat. Med. 2013;2013:789764. doi: 10.1155/2013/789764.
- Baillon L., Basler K. Reflections on cell competition. Semin. Cell Dev. Biol. 2014;32:137–144. doi: 10.1016/j.semcdb.2014.04.034.
- Sanchez I., Dynlacht B.D. New insights into cyclins, CDKs, and cell cycle control. Semin. Cell Dev. Biol. 2005;16:311–321. doi: 10.1016/j.semcdb.2005.02.007.
- Santamaria D., Ortega S. Cyclins and CDKS in development and cancer: Lessons from genetically modified mice. Front. Biosci. 2006;11:1164–1188. doi: 10.2741/1871.
- Sola S., Morgado A.L., Rodrigues C.M. Death receptors and mitochondria: Two prime triggers of neural apoptosis and differentiation. Biochim. Biophys. Acta. 2013;1830:2160–2166. doi: 10.1016/j.bbagen.2012.09.021.
- Cerqueira A., Martin A., Symonds C.E., Odajima J., Dubus P., Barbacid M., Santamaria D. Genetic characterization of the role of the Cip/Kip family of proteins as cyclin-dependent kinase inhibitors and assembly factors. Mol. Cell. Biol. 2014;34:1452–1459. doi: 10.1128/MCB.01163-13.
- Kasibhatla S., Tseng B. Why target apoptosis in cancer treatment? Mol. Cancer Ther. 2003;2:573–580.
- Khan K.H., Blanco-Codesido M., Molife L.R. Cancer therapeutics: Targeting the apoptotic pathway. Crit. Rev. Oncol. Hematol. 2014;90:200–219. doi: 10.1016/j.critrevonc.2013.12.012.
- Asare G.A., Afriyie D., Ngala R.A., Abutiate H., Doku D., Mahmood S.A., Rahman H. Antiproliferative activity of aqueous leaf extract of Annona muricata L. on the prostate, BPH-1 cells, and some target genes. Integr. Cancer Ther. 2015;14:65–74. doi: 10.1177/1534735414550198.
- Zorofchian Moghadamtousi S., Karimian H., Rouhollahi E., Paydar M., Fadaeinasab M., Abdul Kadir H. Annona muricata leaves induce G(1) cell cycle arrest and apoptosis through mitochondria-mediated pathway in human HCT-116 and HT-29 colon cancer cells. J. Ethnopharmacol. 2014;156:277–289. doi: 10.1016/j.jep.2014.08.011.
- Syed Najmuddin S.U., Romli M.F., Hamid M., Alitheen N.B., Nik Abd Rahman N.M. Anti-cancer effect of Annona Muricata Linn Leaves Crude Extract (AMCE) on breast cancer cell line. BMC Complement. Altern. Med. 2016;16:311. doi: 10.1186/s12906-016-1290-y.
- Pieme C.A., Kumar S.G., Dongmo M.S., Moukette B.M., Boyoum F.F., Ngogang J.Y., Saxena A.K. Antiproliferative activity and induction of apoptosis by Annona muricata (Annonaceae) extract on human cancer cells. BMC Complement. Altern. Med. 2014;14:516. doi: 10.1186/1472-6882-14-516.
- Wang X.D., Inzunza H., Chang H., Qi Z., Hu B., Malone D., Cogswell J. Mutations in the hedgehog pathway genes SMO and PTCH1 in human gastric tumors. PLoS ONE. 2013;8:e54415. doi: 10.1371/journal.pone.0054415.
- Jain S., Song R., Xie J. Sonidegib: Mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas. Onco Targets Ther. 2017;10:1645–1653. doi: 10.2147/OTT.S130910.
- Basset-Seguin N., Hauschild A., Grob J.J., Kunstfeld R., Dreno B., Mortier L., Ascierto P.A., Licitra L., Dutriaux C., Thomas L., et al. Vismodegib in patients with advanced basal cell carcinoma (STEVIE): A pre-planned interim analysis of an international, open-label trial. Lancet Oncol. 2015;16:729–736. doi: 10.1016/S1470-2045(15)70198-1.
- Sekulic A., Migden M.R., Oro A.E., Dirix L., Lewis K.D., Hainsworth J.D., Solomon J.A., Yoo S., Arron S.T., Friedlander P.A., et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N. Engl. J. Med. 2012;366:2171–2179. doi: 10.1056/NEJMoa1113713.
- Fecher L.A., Sharfman W.H. Advanced basal cell carcinoma, the hedgehog pathway, and treatment options—Role of smoothened inhibitors. Biologics. 2015;9:129–140. doi: 10.2147/BTT.S54179.
- Lacouture M.E., Dreno B., Ascierto P.A., Dummer R., Basset-Seguin N., Fife K., Ernst S., Licitra L., Neves R.I., Peris K., et al. Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma. Oncologist. 2016;21:1218–1229. doi: 10.1634/theoncologist.2016-0186.
- Kainu K., Kivinen K., Zucchelli M., Suomela S., Kere J., Inerot A., Baker B.S., Powles A.V., Fry L., Samuelsson L., et al. Association of psoriasis to PGLYRP and SPRR genes at PSORS4 locus on 1q shows heterogeneity between Finnish, Swedish and Irish families. Exp. Dermatol. 2009;18:109–115. doi: 10.1111/j.1600-0625.2008.00769.x.
- Bhutani T., Abrouk M., Sima C.S., Sadetsky N., Hou J., Caro I., Chren M.M., Arron S.T. Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib. J. Am. Acad. Dermatol. 2017;77:713–718. doi: 10.1016/j.jaad.2017.03.038.
- Deep G., Kumar R., Jain A.K., Dhar D., Panigrahi G.K., Hussain A., Agarwal C., El-Elimat T., Sica V.P., Oberlies N.H., et al. Graviola inhibits hypoxia-induced NADPH oxidase activity in prostate cancer cells reducing their proliferation and clonogenicity. Sci. Rep. 2016;6:23135. doi: 10.1038/srep23135.
- Dai Y., Hogan S., Schmelz E.M., Ju Y.H., Canning C., Zhou K. Selective growth inhibition of human breast cancer cells by graviola fruit extract in vitro and in vivo involving downregulation of EGFR expression. Nutr. Cancer. 2011;63:795–801. doi: 10.1080/01635581.2011.563027.
- Chamcheu J.C., Afaq F., Syed D.N., Siddiqui I.A., Adhami V.M., Khan N., Singh S., Boylan B.T., Wood G.S., Mukhtar H. Delphinidin, a dietary antioxidant, induces human epidermal keratinocyte differentiation but not apoptosis: Studies in submerged and three-dimensional epidermal equivalent models. Exp. Dermatol. 2013;22:342–348. doi: 10.1111/exd.12140.
- Chamcheu J.C., Lorie E.P., Akgul B., Bannbers E., Virtanen M., Gammon L., Moustakas A., Navsaria H., Vahlquist A., Torma H. Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: Trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition. J. Dermatol. Sci. 2009;53:198–206. doi: 10.1016/j.jdermsci.2008.11.003.
- Chamcheu J.C., Adhami V.M., Esnault S., Sechi M., Siddiqui I.A., Satyshur K.A., Syed D.N., Dodwad S.M., Chaves-Rodriquez M.I., Longley B.J., et al. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice. Antioxid. Redox Signal. 2017;26:49–69. doi: 10.1089/ars.2016.6769.
Source: PubMed